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Abstract
The United States has a significant diabetes problem. This chronic disease affects the
body physically and mentally. One of the emotional effects of diabetes is depression.
Depression is often present in individuals with diabetes, chiefly in those with type 2
diabetes mellitus (T2DM). While depression is common in T2DM and can interfere with
treatment adherence, clinician screening for depression in T2DM patients is low. The
purpose of this study was to examine clinicians’ attitudes, behaviors, and perceptions
concerning screening patients with T2DM for depression. Through a qualitative case
study approach centered on reasoned action theory, 3 physicians and 5 nurse practitioners
who treated T2DM patients were interviewed. The clinicians were interviewed regarding
their screening experience for T2DM for depression. Interviews were recorded,
transcribed and analyzed using thematic analysis. Three themes emerged from the data to
explain clinicians’ screening of T2DM patients for depression: 1) clinicians’ focus on
treating the physical disease of diabetes rather than comorbid depression, 2) T2DM
depression screening is accepted as a standard of care or part of the clinical assessment
process, and 3) there is favorable perception of peer approval for T2DM depression
screening. Implications for social change relate to the need for those with T2DM to
receive effective and efficient screening and treatment for depression. The role of
diabetes clinicians could provide a consistent point of care for screening and referral for
filling this need. Development of best practice guidelines and relevant education
supporting this role could be pivotal in addressing the complication of depression in
T2DM.
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Chapter 1: Introduction to the Study
Diabetes is a chronic disease that is a severe global health problem. In 2010, the
International Diabetes Federation provided statistics showing that 330 million individuals
have diabetes worldwide. (Centers for Disease Control and Prevention [CDC], 2014).
The occurrence of diabetes in Western societies is rapidly rising, and global healthcare
expenditures for diabetes are expected to total $490 billion by 2030 (CDC, 2014). In the
United States, diabetes effects many people, and Type 2 diabetes in young adults is
growing at an alarming rate (CDC, 2015). Diabetes affects an individual’s physical and
mental health, life expectancy, and can cause physical complications (CDC, 2014) that
lead to depression. Depression is a comorbid disease with diabetes (Heckbert, Rutter,
Oliver, Williams, Ciechanowski, Katon, & Von Korff, 2010), meaning that depression
can present simultaneously in a patient living with diabetes.
This study focused on depression in adults with Type 2 Diabetic Mellitus (T2DM)
and indicated how physicians screen patients with T2DM for depression. This chapter
provides background information concerning T2DM and depression. The next section
addresses the statement of the research problem, the purpose and nature of the study, and
the research questions. I also discuss the research methodology, definitions, assumptions,
scope, delimitations, limitations, and significance of the study, and end with a summary
of the chapter.
Background
In the United States, 30.3 million people, or 9.4% of the population, have
diabetes. T2DM accounts for 90% to 95% of those living with diabetes (CDC, 2017).
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Diabetes is diagnosed in individuals of all ages each year. According to the CDC (2017),
diabetes rates as the seventh leading cause of death in the United States. The financial
cost of diabetes in the United States was assessed to be $176 billion in direct health costs,
such as medical services, and $69 billion in indirect expenses from missing workdays,
limited activity, disability, and early mortality (CDC, 2014).
Diabetes is a metabolic disorder caused by genetic and environmental factors that
lead to an unusually high blood sugar level know as diabetes mellitus (DM), which
indicates impaired insulin secretion. Insulin secretion is a process in the human body that
primarily occurs in response to glucose levels becoming elevated in the blood. Insulin
resistance increases the hepatic production of glucose, making insulin levels inadequate
to normalize plasma glucose levels. Causes of diabetes include heredity, poor diet,
lifestyle, gender, stress, and lack of exercise (CDC, 2014).
Individuals with parents who have diabetes are most likely to develop the disease,
and the incidence of diabetes seems to increase with age (CDC, 2015). Dietary deficits in
fiber, protein, and overall nutrition may contribute to diabetes. A lifestyle that does not
include regular exercise and includes high stress may contribute to developing diabetes
(CDC, 2015). Ethnic groups including African Americans, Hispanics/Latinos, Indians,
Asians, and Native Hawaiians or Pacific Islanders are at a higher risk for developing
T2DM than Whites (CDC, 2014).
Depression is one of the complications of T2DM and is two to three times more
prevalent in persons with T2DM than in the general population (Carpenter, 2010).
Individuals with T2DM have an increased likelihood of developing a major depressive
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disorder, debility, health deterioration, high healthcare expenditures, and premature
mortality (O’Connor, Crain, Rush, Hanson, Fischer, & Kluznik, 2009). Signs of
individuals with T2DM depression involve a decline in sexual desire, alteration in
appetite, and sleep alteration.
Feeling sad for more than two weeks is considered the onset of depression (Yim,
Adelina, Tsang, & Leug, 2009). Antidepressants and counseling have shown to
effectively reduce major depression and improve glycemic control in a person with
T2DM (Yim et al., 2009). Individuals with depression may display anger and guilt; both
are commonly seen in people with chronic diseases like diabetes (Ahlin & Billhult,
2012). Depression in the T2DM population is also related to poor health-behavior
compliance, which can negatively affect disease management (Ducat, Philipson, &
Anderson, 2014). The medical costs for treating individuals with T2DM in the United
States is $10,016 annually (Bogner & de Vries McClintock, 2016). An individual
diagnosed with T2DM depression may have medical costs of approximately $15,155 for
annual medical treatments (Egede, Walker, Bishu, & Dismuke, 2016). Individuals with
T2DM and unrecognized depression could result in medical cost of approximately
$16,134 for annual treatments (Bogner & de Vries McClintock, 2016). Additionally,
individuals with T2DM and asymptomatic depression incurred a medical cost of
approximately $20,105 for annual treatments (Egede, Walker, Bishu, & Dismuke, 2016).
A comprehensive approach to treating individuals with T2DM might prove
beneficial to treating the onset of disease complications; however, the American Diabetes
Association’s (ADA) national guidelines for treating individuals with T2DM currently do

4
not include screening patients for depression (National Diabetes Statistics, 2011). It is
recommended that individuals with chronic diseases change their daily routines to
manage their chronic illness. T2DM is a chronic disease that requires individuals to
incorporate new methods to accommodate the complications of their illness, which can
sometimes lead to depression (Mezuk, 2011). Recommendations to assist individuals
diagnosed with T2DM are maintain a healthy lifestyle include exercise regimens,
preparation of specialized meals, and following time schedules for medications; these
requirements can cause high-stress levels as individuals with diabetes work to regulate
their bodies’ glucose (Heckbert et al., 2010).
Individuals with diabetes are more likely to experience depression and diminished
health than those without diabetes (Egede & Ellis, 2010). Depression can emerge in
individuals with T2DM due to the prolonged stress that can result from living with a
chronic illness (Egede & Ellis, 2010). Adopting a comprehensive approach to treating
individuals with T2DM may prove beneficial to treating the onset of disease
complications that may result due to bouts of depression.
Problem Statement
Despite an abundance of research that examined the relationship between diabetes
and depression in the general population (Yu, Y-Hua, & Hong, 2010), there is no
research that examines managing depression in patients with T2DM. Additionally, there
are no studies that have examined physicians’ depression-screening behavior during
routine medical examinations for diabetes. Due to this lack of research, there is still a
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need to examine physicians’ attitudes and behaviors concerning screening individuals
with T2DM for depression.
Because physicians lack the practice of depression screening, individuals with
T2DM are often undiagnosed during the early stages of depression onset (Culman, Guja,
Mihai, & Serafinceanu, 2013), resulting in disease management being compromised for
these patients (Culman, Guja, Mihai, & Serafinceanu, 2013). Researchers have
demonstrated a connection between diabetes and depression; however, screening for
depression in individuals with T2DM is unlikely to occur (Heckbert, Rutter, Oliver,
Williams, Ciechanowski, Lin, Katon, & Von Korff, 2010). Therefore, it is essential to
establish criteria for adequate treatment of individuals with T2DM who suffer from
depression, which could lead to improving their quality of life (Pouwer, 2017). Based on
Connor, Crain, Rush, Hanson, Fisher, and Kluznik (2009), research revealed that
depression and diabetes have a bidirectional relationship, which shows the importance of
managing T2DM depression. Many physicians fail to treat the psychosocial and
emotional difficulties of T2DM (Beverly, Hultgren, Brooks, Ritholz, Abrahamson, &
Weinger, 2011). There is an important need for physicians to recognize depression in
patients with T2DM (Culman, Guja, Mihai, & Serafinceanu, 2013). Screening for
depression and providing integrating psychosocial and behavioral healthcare to T2DM
patients could ensure that physicians manage both diseases (Egede & Ellis, 2010).
According to Beverly et al. (2011), physicians reported limited patient-treatment
choices, time limits of patient appointments, and a lack of mental disorder expertise,
leading to feelings of frustration, inadequacy, and being overwhelmed. The development
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of efficient psychological testing and short-term psychosocial interventions that doctors
used were essential to individuals’ health; however, they should not replace mental wellbeing referrals (Beverly et al., 2011). Medical preparation and training should address
psychosomatic complications that frequently occur in patients with prolonged illnesses.
Doctors and patients may benefit from a multidisciplinary team method in which team
members supplement care by providing assessment and treatment for patients’
psychosocial and emotional complications (Beverly et al., 2011).
From economic, public health, and humanitarian standpoints, identifying and
treating mental health comorbidities among diabetes patients should be a priority (Ducat
et al., 2014). Individuals with T2DM are particularly vulnerable to mental health
comorbidities, as they experience challenges in their ability to maintain an average
glucose level and risk a medical loss to follow-up on poor health outcomes. Creating an
opportunity to integrate mental health screening and treatment into multidisciplinary team
care for T2DM could improve patient and public health outcomes and help decrease
healthcare expenditures (Ducat et al., 2014). According to ADA (2014) standards of care,
people with T2DM should receive medical attention from a panel of healthcare
professionals that includes physicians (medical practitioners, general practitioners, and
internal medicine), nurse practitioners, physician’s assistants, nurses, dietitians,
endocrinologist, pharmacists, and psychiatrists with expertise in diabetes.
A limited number of diabetic clinics offer mental health screening or incorporate
mental and behavioral health services for T2DM in diabetes clinical care (Garrusi,
Baneshi & Moradi, 2013). According to Ducat et al. (2014), it is neither realistic nor
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affordable to use standardized psychiatric diagnostic interviews to diagnose mental health
comorbidities in individuals with T2DM. T2DM depression interferes with individuals’
disease management, and there is a need to identify screening behaviors among
physicians. Understanding the clinicians’ viewpoints as to why physicians may or may
not screen T2DM patients for depression could result in the development of a T2DM
screening plan to treat both T2DM and depression.
Purpose of the Study
The purpose of the study was to examine clinician behaviors and attitudes towards
screening for depression in patients with T2DM. In this qualitative study, I explored how
doctors describe their perspectives and behaviors relating to depression screening in their
patients with T2DM.
Research Questions
The investigation questions that guided this study were:
1. How do physicians and nurse practitioners describe their attitudes toward
screening T2DM patients for depression?
2. How do physicians and nurse practitioners describe their T2DM depressionscreening behaviors?
3. How do physicians and nurse practitioners describe their perceptions of
whether their peers support screening T2DM patients for depression?
These open-ended questions align with tenets guiding on qualitative inquiry (Creswell,
2007). The questions served as a structure to engage the participants as explored by the
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clinician’s perspective and behavior when screening individuals with T2DM for
depression.
Conceptual Framework
Scholars have used the theory of reasoned action (TRA) to explain a range of
clinical practices among physicians and other healthcare professionals (Ajzen &
Fishbein, 1980). TRA is a model used to explain behavior that emphasizes behavioral
intention, attitudes, and subjective norms (Ajzen & Fishbein, 1980). Behavioral intention
measures the probability that an individual would participate in a particular behavior or
harbor the intent to implement or not implement a given behavior (Ajzen & Fishbein,
1980; Thrasher, Andrew, & Mahony, 2011).
The behavioral intention has two factors, one individual in nature and the other
reflecting social impact. The personal influence is the individual’s positive or negative
assessment of executing the behavior or attitude regarding the behavior (Ajzen &
Fishbein, 1980, p. 6). Attitude or viewpoint refers to the degree to which an individual
has an encouraging or undesirable assessment or review of the behavior in question.
Personal norms relate to an individual’s beliefs about whether peers and individuals of
importance believe they should engage in the behavior (Thrasher et al., 2011). An
individual may evaluate viewpoint and personal norms directly or indirectly. The direct
assessment of attitude is the overall evaluation of conduct. The indirect assessment rests
on a person’s beliefs that engaging in the behavior aligns with specific consequences
(behavioral beliefs), weighed by evaluating that result (Ajzen & Fishbein, 1980, p. 6).
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A behavioral view of screening people with T2DM for depression may result in
the likelihood that screening would enhance patient health choices and may be weighed
by the person’s evaluation that the behavioral outcome of improving the health of
individuals with T2DM is good (Ajzen & Fishbein, 1980). The direct assessment of
attitude is the overall evaluation of the behavior (screening a T2DM patient for
depression is right or wrong). An indirect assessment of a person’s attitude is related to
the individual’s belief that engaging in the behavior is associated with specific
consequences (behavioral beliefs), weighed by an evaluation of that result (Ajzen &
Fishbein, 1980).
The direct measure is the individual’s overall evaluation of whether social
referents approve or disapprove of behavior (Ajzen & Fishbein, 1980). The secondary
measure is the person’s belief that each specific referent endorses or rejects behavior,
weighed by the individual’s motivation to comply with referents’ perspectives.
Clinicians’ opinions of colleagues’ endorsement or lack of endorsement of screening
those with T2DM for depression are likely to influence their motivation to screen. I used
TRA, which was the foundational theoretical model for this study. It is useful as an
analysis of clinicians’ intention to screen T2DM patients for depression. I explored how
doctors and nurse practitioners describe their perspectives and behaviors relating to
depression screening in their patients with T2DM.
Nature of the Study
This qualitative case study focused on how clinicians screen patients with T2DM
depression. Purposive sampling, in-depth interviews, and semi-structured questions were
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used in this research (Creswell, 2007). Focus groups were not considered in this study
because I wanted the participants to discuss their experiences in a private setting and
avoid the tendency of not being completely honest because of what others in a group
setting might think.
Quantitative and mixed methods were not appropriate because this study was not
about numbers and trend analysis (Creswell, 2014). I recorded the interviews, and the
recordings were transcribed, using NVivo to develop categories (Creswell, 2014). NVivo
software is an aid in manipulating the data, developing codes, and categorizing the data
(Creswell, 2014).
This qualitative research used purposeful sampling; this means that the inquirer
selects individuals and sites for the study to purposefully understand the research problem
in the case study (Creswell, 2007). According to Creswell (2007), the recommendation
for conducting a qualitative case study should contain no more than five to ten
participants in a single study. This sample provided sufficient opportunity to identify
themes of the cases and conduct cross-case theme analysis (Creswell, 2007).
Definitions
Definitions presented below include biological and medical terms and diagnostic
tools used in this dissertation.
Blood cholesterol: This is a type of fat produced by the liver, found in the blood
and some foods. The body uses cholesterol to make hormones and build cell walls (CDC,
2014).
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Blood glucose: This is sugar in the blood that provides the body with the primary
source of energy (CDC, 2014).
Comorbidity: This consists of two or more diseases or conditions in patients.
Comorbidity sometimes refers to complications in the disease (CDC, 2014).
Depression: This is a mood disorder that causes a continuous feeling of anxiety,
sadness, misery, withdrawal from society, and loss of interest (CDC, 2014).
Depression screening: This is a mental health tool used to determine if an
individual is depressed. Depression screening is used to determine if individuals are
feeling an overwhelming sadness (CDC, 2014).
Diabetes: This is a metabolic disorder that involves multiple organs, including the
brain and central nervous systems. High blood glucose or hyperglycemia results from the
body’s inability to use blood glucose for energy (CDC, 2014).
Diabetes Mellitus (DM): Classified as impaired insulin secretion and peripheral
insulin resistance, this increases hepatic production of glucose, making insulin levels
insufficient to regulate plasma-glucose levels (CDC, 2014).
Diagnosing diabetes: This includes a diabetes atlas application. A person is
considered to have been diagnosed with diabetes if a doctor or other medical health
professional told an individual they had diabetes. Women who had diabetes during
pregnancy are not considered to have diabetes (CDC, 2014).
Hypoglycemia: This is low blood glucose. It is a disorder that occurs when one’s
blood glucose is lower than usual or below 70mg/dl. Signs include hunger, nervousness,
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tremors, sweat, faintness or dizziness, lethargy, and confusion. If left untreated,
hypoglycemia may lead to unconsciousness (CDC, 2014).
Neuropathy: This is an ailment of the nervous system that causes muscle
weakness, ache, and numbness. The most common form of neuropathy in people with
diabetes is peripheral neuropathy, which affects the legs and feet (CDC, 2014).
Obesity: This is a disorder in which a person has a higher than average amount of
fat in the body or has a body-mass index of 30 or more (CDC, 2014).
Type 2 Diabetes Mellitus (T2DM): This is an ailment categorized by high bloodglucose levels caused by the lack of insulin or the body’s incapacity to use insulin
efficiently. Individuals with T2DM often develop the illness during middle-age. T2DM
can appear in children and teens, as well as adults (CDC, 2014).
Theory of Reason Action Model Constructs
Behavior: This is the transmission of intention or perceived behavioral control
into action (Ajzen & Fishbein, 1980).
Behavioral Intention: This is an indication of how hard people are willing to try
and how much effort they are planning to use to perform a behavior (Ajzen & Fishbein,
1980).
Attitude: This is the first determinant of behavioral intention. It is the degree to
which the person has a favorable or unfavorable evaluation of the behavior in question
(Ajzen & Fishbein, 1980).
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Subjective Norm: This is considered the second predictor of behavioral intention,
and it is influenced by social pressure to perform or not perform a specific behavior
(Ajzen & Fishbein, 1980).
Perceived Behavioral Control: This is the third precursor of behavioral intention
(Ajzen & Fishbein, 1980). This construct is defined as the person’s belief concerning
how easy or difficult performing the behavior will be (Ajzen & Fishbein, 1980).
Assumptions
The following assumptions relate to participant responses and the data used in the
analysis portion of the research. The first assumption was that participants have an
opinion about T2DM screening for depression. The second assumption was that
clinicians were thoughtful and honest in their answers to the research questions. The third
assumed that clinicians had experience treating patients with T2DM depression. The
fourth assumption was that participants who agreed to participate met the study’s criteria.
Scope and Delimitations
Physicians and nurse practitioners were invited to participate in this case study
research. Participants were recruited from Saint Louis, Missouri, and the following cities
in Mississippi: Charleston, Horn Lake, Calhoun City, Pora, Hernado, and Pope. Specialty
areas of participants included medical practitioner, general practitioner, endocrinologist,
family medicine, and internal medicine. The focus was on physicians’ and nurse
practitioners’ treatment process for patients with T2DM accompanied by depression.
Participants were provided information about their clinic processes for T2DM depression
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treatment. There was no way to identify which participants made which statement. Study
results were not generalized due to the limited number of five to seven participants.
Limitation
This research study is limited to a focus on clinicians’ screening of patients with
T2DM for depression. Another limitation was that if physicians and nurse practitioners
understand T2DM depression exists and if they included screening of patients with
T2DM for depression. A potential weakness of the study was not knowing if physicians
integrated T2DM depression screening into their daily clinical practice. The final
limitation of the study was that the data collected from a small group may not have
yielded an accurate picture of the present population, and generalization of the results
may have been ambiguous because of the limited number of interviews.
Significance
This study produced significant knowledge and additional insight into T2DM
depression screenings. The study and research questions aimed to examine clinicians’
attitudes and behaviors concerning screening patients with T2DM for depression.
According to Ajzen and Fishbein (1980), the attitude was populated to be the primary
factor of behavioral intention. The individual attitude towards behavior is the degree to
which one has a positive or negative belief about performing a correct behavior. An
individual is intended to implement a particular behavior when he or she assesses it to be
positive or an individual does not intend to perform a particular behavior when he or she
evaluates it to be negative (Ajzen & Fishbein, 1980).
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According to Ajzen and Fishbein (1980), subjective norms or normative beliefs
are considered the second predictor of behavioral intention. Subjective norms or
normative beliefs are the peer pressures interpreted by the individual to exhibit or not
exhibit a particular behavior (Ajzen & Fishbein, 1980). An individual is intended to
perform a specific behavior when he or she perceives what others think they should
(Ajzen & Fishbein, 1980). An individual not intending to implement a specific behavior
once they perceive that it is not necessarily based on if others think (Ajzen & Fishbein,
1980). The behavioral intention was weighed by the individual’s desire to comply with
perceived expectations. Perceived behavioral control is the third precursor of behavioral
intention (Ajzen & Fishbein, 1980).
Understanding behavioral control refers to the degree to which some individuals
feel that accomplishing or not accomplishing the behavior in question is under their
control (Ajzen & Fishbein, 1980). People are not likely to form an opinion to perform a
behavior if they do not have resources or opportunities to do so, even if they hold positive
attitudes toward the behavior and believe that others would approve of it (Ajzen &
Fishbein, 1980). Understanding behavioral control can influence behavior directly or
indirectly through behavioral intentions. A route from perceived behavioral control to
behavior is likely to emerge when there is some agreement between the control’s
perceptions and the person’s actual control over the behavior (Ajzen & Fishbein, 1980).
This study has information for medical professionals, improving their
understanding of the level of T2DM depression, thereby allowing them to treat
individuals with diabetic depression appropriately. This study’s outcome provided the
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medical community with additional knowledge on how to screen individuals with T2DM
depression. Educating health professionals on types of depression is one approach to
improving T2DM depression care. Continuing education programs would enhance
providers’ intentions, confidence, and skills to address depression in patients with T2DM.
Healthcare professional training on depression scales for T2DM should be current,
credible, focused, engaging, comfortable to use, and convenient for the doctors (Osborn
et al., 2010). It is essential to providing the medical community with an understanding of
the psychological, emotional, and social impact of T2DM depression (Speight, Browne,
Holmes-Truscott, Hendrieckx, & Pouwer, 2012). Physicians need to support people
living with T2DM depression, promote positive health habits, and enhance the health and
well-being of the T2DM population (Nelson & Prilleltensky, 2005). This study could
bring increased awareness regarding the doctors’ current behaviors and practices treating
the T2DM population.
Summary
A need exists to increase T2DM depression awareness by screening diabetic
patients. This diabetic screening goal was attained by incorporating screening tools for
depression as part of regular diabetes procedures (Schram, Baan, & Pouwer, 2009).
Acknowledging depression in individuals with diabetes is suboptimal. A universal
approach to launching comprehensive interventions to improve early detection of
depression and early initiation of treatment for depression is required to reduce the
world’s depression burden among individuals with diabetes (Egede & Ellis, 2010).
Medical professionals should consider periodic screening for depression and initiate
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treatment. Understanding this complex co-occurring condition is essential, and healthcare
personnel must strive to address diabetes depression adequately (Pirraglia & Gupta,
2007).
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Chapter 2: Literature Review
Introduction
The research purpose of this study is to explore physicians’ and nurse practitioners’
perceptions and behaviors regarding screening patients with T2DM for depression. The emphasis
of this research study was to examine clinicians’ behavior and impact of peer influence on
screening T2DM patients for depression. There are no research studies that examine how
primary care physicians, endocrinologists, nurse practitioners, and internal medicine physicians
screen individuals with T2DM for depression. This chapter reviews the literature on diabetes,
T2DM, deficiency of depression screening, psycho-diagnostic, depression, cost of T2DM
treatment, and the TRA.
Depression in diabetic patients is often unrecognized and untreated because of the
similarity to somatic symptoms (Culman et al., 2013). Another reason for the deficiency of
depression screening for diabetes patients includes clinicians improperly trained to perform
psycho-diagnostic interviews (Culman et al., 2013). Healthy individuals who do not have a
chronic disease such as diabetes may not experience an increase in their annual healthcare cost.
However, for individuals who develop chronic diseases such as diabetes, healthcare costs may
increase, resulting in feelings of depression. My qualitative research focus was on T2DM,
depression, and clinicians’ behavior toward T2DM depression screening.
Literature-Search Strategy
The literature search was conducted using an online questionnaire to identify peerreviewed articles from January 1990 through June 2017 using Thoreau and Walden University’s
discovery service. Walden University’s discovery services include several databases. The
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following are resources from the databases: Thoreau, Biomed Central, CINAHL, EBSCOhost,
Elsevier, JAMA, and Google Scholar. Additional databanks perused were Medline, Psych
Articles, PsycINFO, Social Science, Sage, ProQuest, Web of Science, PubMed, and Science
Direct peer-reviewed journal articles. The search consisted of retrieving full English text from
published journal articles. Key terms were diabetes, diabetic, non-insulin-dependent diabetes
mellitus, depression, and comorbidity of T2DM, combined with depression or depressive, mood
disorder, depressed mood, risk factors, complications, glycemic control, mortality, and
healthcare costs.
Conceptual Framework
Ajzen and Fishbein (1980) define TRA as a general theory explaining individual
behaviors and identifying intention determinants. According to TRA, a person’s intention is a
function of two primary determinants, one person in nature and the other reflecting social
influence (Ajzen & Fishbein, 1980). The particular factor is the individual’s positive or negative
evaluation of performing a behavior; this aspect is the behavior’s attitude. The second
determinant of the intention is the person’s perception of the social pressures to perform or not
perform the behavior in question (Ajzen & Fishbein, 1980). According to TRA, individuals plan
to perform a behavior when they evaluate it positively and believe that significant others think
they should perform it (Ajzen & Fishbein, 1980). TRA serves as the theoretical framework for
this study. Examining physicians’ behavior using the TRA as a theoretical lens, this study
explored clinicians’ depression-screening behaviors, attitudes toward screening, and perceptions
of social peer approval toward screening patients with T2DM for depression.
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TRA is a model explaining individual behaviors, emphasizing intention, attitudes, and
perceptions of whether peers support a particular activity (National Institutes of Health [NIH],
2012). According to TRA, an individual who believes performing a given behavior would lead to
a positive outcome would hold a favorable attitude toward performing that behavior and would
be more likely to carry out the behavior. Similarly, if an individual believes others approve of the
behavior, he or she would be more likely to hold a positive attitude toward it and be more likely
to perform the behavior. In this study, I used TRA to identify why clinicians may or may not
hold favorable attitudes toward screening for depression in T2DM patients. I further used TRA
in this study to understand clinicians’ attitudes toward screening for depression and how those
attitudes are similar in intentions to monitor individuals with T2DM for depression.
Qualitative Case Studies
Creswell (2009) recommended that qualitative researchers choose from among the
possibilities of narrative, phenomenological, ethnographic, case, and grounded-theory study.
Currently, these methodologies are widespread across social and health sciences (Creswell,
2009). Case studies are a plan of inquiry in which the investigator explores in depth a program,
event, activity, process, individual, or group (Creswell, 2009). A case study is limited to time,
activity, and the researcher’s ability to gather comprehensive information, exhausting an
assortment of data collection procedures over a continued period (Creswell, 2009). This process
encompasses using numerous points of data collection and the refinement and interrelationship
of categories of information (Creswell, 2009).
Case studies are standard in the medical field to investigate or search for understanding of
behavior and the psychosocial impact of a group of medical professionals. For example, the
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nursing staff’s confidence in their knowledge of prostate cancer’s psychosocial influence was
explored using a case study research approach (Williams, Hemphill, & Knowles, 2017). In one
example of a case study on the practice of social work in health care in the Czech Republic, the
researcher worked to understand social work practice in healthcare through exploration
(Kuznikova, 2017). Another example of a case study was a UK education program affecting
healthcare professionals to recommend exercise for their patients with T2DM, which enabled
them to understand their processes (Matthews, Jones, Thomas, van den Berg, & Foster, 2017).
Lastly, an example of a single-case cross sectional study was conducted to understand the
dissemination of an accident, emergency, attendance, and hospital admissions for the casemanaged population (Phillips, Jones, Runacres, Lintern, & Radford, 2016).
Qualitative Concerns and Procedures
Qualitative researchers usually do not test concepts or assumptions. It is essential to
deliberate critical concepts from related information that contribute to current understanding and
concepts that assist in data interpretation qualitative case study should be conducted to
understand T2DM depression screening behaviors. In this project, I studied clinicians’ current
screening behaviors, attitudes, and perceptions of whether their peers support screening patients
with T2DM for depression.
For this study, the interviewees consisted eight clinicians. This sample size achieved
saturation of themes as suggested by Isaacs, 2014. A snowball sampling technique was used to
identify potential interviewees for this study. Snowball sampling is where research participants
recruit other participants for a study. The demographic data collected described the sample and
includes specialty, age, gender, and years of practice.
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This qualitative case study focused on the experience of clinicians treating individuals
with T2DM. Questions pertained to clinicians’ experience and processes, and attributes toward
treating patients with T2DM. A qualitative case study design was employed because it permits
clinicians to describe their process for screening patients with T2DM for depression.
Literature Review Related to Key Variables and/or Concepts
Type 2 Diabetic Mellitus and Depression
T2DM is a long-lasting metabolic disorder (Kolluru, Bir, & Kevil, 2012) that causes an
individual to develop abnormal blood-glucose levels, carbohydrates, fat metabolism, and protein
metabolism (Abbas et al., 2015). The human body converts food into glucose (sugar) for the
body to consume as energy. The pancreas is an organ located between the stomach and spine that
produces hormones commonly referenced as insulin. Insulin transfers glucose from the blood
into muscle, fat, and liver cells to power the human body (CDC, 2014). Individuals with DM
produce insufficient insulin. If individuals do not produce adequate amounts of insulin, sugar
accumulates in the bloodstream (CDC, 2014). Individuals with DM are at a higher risk of
developing a range of comorbidity complications due to the disease (CDC, 2014).
Diabetes generates serious health problems: chronic renal disease, cardiovascular disease,
diabetic eye disease, lower extremity amputations, and comorbidities such as depression.
Depression and diabetes are linked; therefore, better management of DM could reduce patients’
likelihood of experiencing an episode of depression (Abbas et al., 2015; Alderson, Foy,
Glidewell, & House, 2014).
Diabetes is the seventh leading cause of death in the United States (CDC, 2014).
Individuals who develop T2DM contract non-insulin-dependent diabetes mellitus or adult-onset
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diabetes. T2DM individuals account for roughly 90 to 95% of all identified cases of diabetes.
Risk factors for developing T2DM are age, weight, family history, occurrence of gestational
diabetes, physical activity, and race or ethnicity. Nearly 8.1 million individuals with diabetes do
not realize they have the disease due to prediabetes and T2DM having limited physical
symptoms. Therefore, some individuals might not realize the severity of the disease (CDC,
2014). In the United States, diabetes trends have nearly multiplied within 5 years, from 5.5
million to 21.3 million adult cases. Each year, healthcare personnel report 1.7 million new adult
cases of diabetes. If this trend continues, one of every three adults in the U.S. might haveT2DM
diabetes by 2050 (CDC, 2014).
Type 2 Diabetic Mellitus and Depression Symptoms
T2DM depression causes feelings of sadness, anxiety, and withdrawal from society
(Auslander, Sterzing, Zayas, & White, 2010). Mental illness symptoms include depression, sad
mood, reduced interest in activities, weight change, psychomotor tension, exhaustion,
inappropriate remorse, and difficulties focusing (CDC, 2014). One of the diagnostic criteria
established by the American Psychiatric Association suggested five or more characteristics or
symptoms must be present for a continuous period of 2 weeks to be classifiable as depression
(CDC, 2014). An individual with T2DM might suffer from one or more depressed mood
symptoms, may develop insomnia from worries about uncontrollable glycemic levels, or have a
negative self-concept (Yim et al., 2009). Depression is a condition that affects cognition,
behavior, and the nervous system, leading to significant dysfunction in an individual’s daily life
and occupation.
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Treatment for depression consists of psychotherapy, drugs, and individual counseling.
Depressed patients have a high risk of suicidal ideation, and some depression treatment offers
patients alternative therapy treatment. For example, aromatherapy is a useful tool to treat
depression. According to Siddique et al. (2014), research showed that T2DM patients have a
higher clinical depression rate than insulin-treated patients. The etiology of depression is
unknown; however, genetic and environmental factors may contribute (Coryell, 2009).
Depression also affects the immune system by reducing the protection response and intensifying
the risk of cardiovascular disorders.
Depression in Type 2 Diabetic Mellitus
Wiltink, Michal, Wild, Schneider, König, Blettner, Beutel, (2014) identified a clear
association between diabetes and depression. Individuals with T2DM risk developing depression,
nervousness, or food-intake disorders (Ducat et al., 2014). Individuals with diabetes may
experience specific emotional difficulties, such as feelings of shame or apprehension when they
fail to persist in their diabetes management. This population may fail to receive treatment due to
inadequate screening for mental health comorbidities such as depression. Clinicians should
identify and treat mental health comorbidities of individuals with T2DM due to the risk that
depression poses to adhering to medical-treatment plans (Alonso-Moran, Satylganova, Orueta, &
Nuno-Solinis, 2014; Ducat et al., 2014). If depression remains untreated, patients with T2DM
may not correctly manage their illness, leading to physical complications.
The connection between diabetes and depression is bidirectional (Heckbert et al., 2010).
Individuals with diabetes have a higher degree of developing depressive illness, and depression
increases diabetes onset and progression (Egede & Ellis, 2010). Symptoms of depression and
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diabetes intensify one another, contributing to a catastrophic cycle of poor self-care, deteriorating
diabetes control, and deepening depression (Culman et al., 2013). However, depression is
considered an insignificant factor, frequently ignored and left untreated by medical professionals
(Zhang, Ajilore, Zhan, GadElkarim, Korthauer, Yang, & Kumar, 2013).
Why Individuals with T2DM are Susceptible to Depression
Depression is a common problem with diabetes; recent meta-analysis acknowledged
depression is two to three times more dominant in individuals with diabetes than in the general
population (Carpenter, 2010). Depression, combined with DM, is a significant burden on
patients’ health (Abbas et al., 2015). Sweileh, Abu-Hadeed, Al-Jabi, and Zyoud (2014)
recommended instituting a psychological assessment in the diabetic healthcare plan, reducing the
number of unrecognized diabetic patients with depression. The researchers also recommended
that routine clinical evaluations include psychosocial assessment conducted by patients’ primary
healthcare clinics to improve patients’ quality of life.
For several years, researchers identified the relationship between depression and diabetes.
Investigators argued that diabetes precede depression and leads to depression through a direct
effect of hyperglycemia. Individuals with diabetes develop depression as a consequence of
psychological tension that elevates the acknowledgment of the diagnosis. Diabetes treatment
requires lifestyle modifications and medication that cause depression symptoms (Holt et al.,
2009). Better management of DM would reduce the likelihood of a patient with diabetes
experiencing an episode of depression (Abbas, Nasir, Zehra, Noor, Jabbar, & Siddqui, 2015, p.
208). Individuals with diabetes develop psychological distress resulting from disease diagnosis.
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Psychosocial interventions for the T2DM population include treating diabetic distress and
depression simultaneously (Carper et al., 2014).
Diabetes and depression mutually worsen the other with each ailment acting as a risk
factor in the development of the other (Zhang et al., 2015). Individuals with T2DM depression
symptoms may experience increased disability, a decline in health, increased medical expenses,
and premature death (O’Connor et al., 2009). A diabetic’s self-care management program
requires balancing a complex set of behavioral tasks. The individual must adhere to prescribed
medications 24 hours a day and maintain their self-care plan overall (Ducat et al., 2014).
Diabetes suffering occurs because almost all diabetic care involves self-management. Selfmanagement tasks for patients with T2DM consist of carefully testing blood glucose levels to
regulate medication doses day and night (Aflakseir, & Malekpour, 2015). Patients with T2DM
balance their insulin level by selecting specific foods to eat and monitoring their blood glucose
levels to prevent hypoglycemia (Ducat et al., 2014). Individuals with T2DM experience specific
emotional complications, such as feeling guilty or depressed when they fail to maintain their
diabetes regimen (Lee, Chapa, Kao, Jones, Kapustin, Smith, & Friedmann, 2009).
A person with diabetes has emotional responses to the experience of having T2DM with a
wide range of stressors, such as feeling overwhelmed with the diabetes regimen (Ducat et al.,
2014). Patients with T2DM are concerned about the future and the possibility of severe
complications and feel guilty when management is going poorly. The disease mandates selfmanagement, causing emotional distress to individuals with T2DM. T2DM psychiatric diagnosis
of depression aligns with poor compliance with treatment, glycemic control, higher percentages
of diabetes complications, and diminished quality of life (Ducat et al., 2014).
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Lifestyle alterations provide persisting inner struggles for the population with T2DM
(Ahlin & Billhult, 2012). This population struggles to prepare healthy food for the family and
lifestyle changes are overwhelming (Pera, 2011). Furthermore, women with T2DM often place
family needs first, causing them to manage their disease inadequately (Pera, 2011). Individuals
with DM feel a loss of independence. They also experience frustration during meticulous
planning around diabetes that can interfere with freedom of choice, particularly in those who are
new to the condition. Emotional distress is a core development for individuals with T2DM, and
healthcare personnel must continuously measure underlying diabetes-related distress (Fisher,
Gonzalez, & Polonsky, 2014). Continuous diabetes distress measurement can lead to suitable and
targeted patient interventions (Fisher et al., 2014). Patients with diabetes should have regular
screening for depression to reduce the number of depressed or misdiagnosed patients, offering
them a healthier quality of life (Zhang et al., 2015).
Treatment for Type 2 Diabetic Mellitus
The American Diabetes Association has developed national guidelines for treating
patients with T2DM. However, the guidelines do not include depression treatment, nor do they
require annual depression screenings for patients with T2DM. Depression can be a severe
problem for patients with diabetes (Gonzalez, Fisher, & Polonsky, 2011). Additionally,
healthcare providers do not educate patients with T2DM about depression or the consequences of
depression for disease management (National Diabetes Statistics, 2011). Consequently, a vast
number of individuals with T2DM are unaware of the symptoms of depression and do not know
to request medical treatment (Agbir, Audu, Adebowale, & Goar, 2010; Yu et al., 2010). Patients
with T2DM have difficulty seeking treatment for depression due to the deficiency of diabetic-
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depression screening in the medical community (De Groot, Kushnick, Doyle, Merrill, McGlynn,
Shubrook & Schwartz, F. 2010).
Incorporating physical and emotional care for patients with T2DM enables treating
clinicians to improve the management of their diseases (Egede & Ellis, 2010). Because
depression and diabetes have a bidirectional relationship, proper T2DM depression screening and
treatment are essential to improving the disease management of individuals with T2DM
(O’Connor, Crain, Rush, Hanson, Fischer, & Kluznik, 2009). Due to the absence of depression
screening by medical professionals treating individuals with T2DM, clinicians do not diagnose
patients during the earlier stages of depression (Pouwer, 2017). Disease management is
compromised for individuals with T2DM because of the lack of depression screening for these
patients (Culman et al., 2013).
Clinicians and Comorbid Depression Screening
Chronic illness is a condition that lasts for years and usually cannot be cured entirely.
Individuals with a chronic illness can develop depression feelings because of the life disruption
the illness may cause. Some chronic illnesses are controllable through diet, exercise, and
medication. For example, chronic illnesses include heart attacks, coronary artery disease,
Parkinson’s disease, multiple sclerosis, cancer, and diabetes. People with prolonged illness
develop depression, which is one of the standard complications. Depression triggered by chronic
illness often worsens the ailment, especially if the illness causes pain and fatigue, or limits a
person’s ability to interact with others (Simon, 2001).
Research on prolonged illnesses and depression suggests that depression frequencies are
high among patients with chronic ailments (Simon, 2001). An individual who has had a heart
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attack, who develops coronary artery disease without having a heart attack, develops Parkinson’s
disease or Multiple Sclerosis, or individuals with cancer and diabetes can exhibit signs of
depression (Simon, 2001). Presently there are standards of care for treating a chronically ill
individual for depression. Individuals with chronic disease rely on their clinicians to assist with
maintaining their health. Clinicians recognize symptoms of depression; believing that anyone
with a chronic illness could be depressed (Simon, 2001).
Clinician’s Attitudes toward Screening T2DM Individuals for Depression
It is essential to understand clinicians’ attitudes toward depression screening for
individuals with T2DM and why clinicians may or may not screen for depression. This study
could promote social change by providing an understanding of clinicians’ attitudes and behaviors
concerning screening patients with T2DM for depression. This study could lead to improving
depression screening in this population by resulting in individuals with T2DM receiving the
psychological care they may need while enduring this chronic illness.
In a study conducted by Yu et al. (2010), depressive tendencies were apparent in many T2DM
patients, however, these tendencies were not acknowledged by healthcare workers. Due to the
link between depression and T2DM, adequate testing would assist physicians in the management
of patients with T2DM by managing concurrent depression (Acee, 2010). According to de Vries
McClintock, Boyle, Rooney, and Bogner (2016), an integrated care intervention employing
patient-prioritized planning that incorporates financial, social, and emotional needs of primary
care patients with T2DM depression may be useful. Similarly, patients need unique and effective
psychological treatment.
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Healthcare teams should develop the ability to efficiently and accurately diagnose
individuals with T2DM for depression instead of labeling them as non-compliant patients
(Culman et al., 2013). Psychosocial and self-management barriers include depression, adherence
to prescription regimens, and dramatic lifestyle changes (Raval, Dhanaraj, Bhansali, Grover, &
Tiwari, 2010). Another barrier includes biological factors such as hormonal changes, lack of
time, and insufficient social support (Bayliss, Ellis, & Steiner, 2007). Psychological attributes
relate to significant barriers that patients with T2DM must address for this chronic disease.
Diabetes presents a challenge for individuals with T2DM because they are overwhelmed by the
time they are required to self-manage, which causes frustration (Chlebowy, Hood, & LaJoie,
2010). Difficulties in maintaining the diabetes health-behavior schedule is another challenge for
individuals with T2DM (Chlebowy et al., 2010).
Healthcare workers often do not recognize depression among individuals with T2DM
(Schram et al., 2009); therefore, patients with T2DM are not treated or screened for depression
during routine medical checkups by their physicians. Clinician acknowledgment and depression
management may be particularly crucial for older adults with T2DM (Kimbro et al., 2014).
Using depression screening tools, such as a Patient Health Questionnaire (PHQ-8 or PHQ-2), can
be an efficient way to recognize depression before it results in an unnecessary health risk that
may lead to mortality (Kimbro et al., 2014). Undiagnosed depression reasons include physicians’
lack of specific training to perform psycho diagnostic interviews (Culman et al., 2013).
Clinicians who lack knowledge of atypical depression symptoms lack psychological
expertise and knowledge of proper depression screening tools for diagnosing T2DM depression
(Beverly et al., 2011). Another barrier interfering with clinicians diagnosing T2DM depression is
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a stigma related to mental illness; clinicians may believe that depression is a normal process in
aging; furthermore, physicians and nurse practitioners may believe that antidepressants interfered
with the treatment of other health conditions or interact with other medications. When clinicians
believe that overlapping symptoms from other chronic diseases explain depression symptoms,
other chronic health conditions take priority during a short medical visit, (Beverly et al., 2011).
Path analysis proposes a reciprocal relationship between depression and functioning
(Schmitz, Gariépy, Smith, Malla, Boyer, Strychar, & Wang, 2013). An example of this is a
decline in functional independence. Psychological and physical changes, along with life stressors
can increase allosteric weight, which may support the development of depression. Patients with
T2DM should obtain an accessible healthcare provider network that includes an endocrinologist,
psychiatrist, and psychologist (Bensbaa, Agerd, Boujraf, Araab, Aaloiane, Rammouz, & Ajdi,
2014). Individuals with T2DM could benefit from meeting with a therapeutic staff aware of the
possible psychological problems while providing diabetes treatment. Targeting diabetes distress
and depression may improve the outcome of psychosocial intervention approaches in the T2DM
population (Carper, Traeger, Gonzalez, Wexler, Psaros, & Safren, 2014).
Clinician Depression-Screening Behaviors
Clinicians recognize diabetes and depression, but do not relate to screening the
population for mental health distress (Heckbert et al., 2010). Furthermore, clinicians who
understand how to use an integrated approach to treating T2DM may offer patients support to
control their chronic illness (Leone, Coast, Narayanan, & de-Graft Aikins, 2012). It is essential
to establish criteria for adequate treatment for individuals with T2DM suffering from depression,
which would improve their quality of life. It is unsafe for clinicians to fail to identify depression
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in patients with T2DM (O’Connor et al., 2009). Despite the potential adverse effects of
psychological health problems on diabetes outcomes and healthcare expenses, only about 1/3 of
patients with these coexisting illnesses obtain a diagnosis and treatment.
Physicians and nurse practitioners face challenges when treating T2DM patients’
psychological and emotional complications (Ducat et al., 2014). Some clinicians report trouble
identifying patients’ emotional complications. The absence of psychological expertise
contributes to clinicians feeling frustrated, inadequate and overwhelmed during T2DM treatment.
In the study conducted by Ducat et al. (2014), physicians remarked on the stress and anxiety of
struggling to adhere to a typical medical visits time limitation. Clinicians may benefit from a
multidisciplinary team approach because the physician’s patient time per visit is limited. A
multidisciplinary team approach would relieve clinicians of the emotional and social difficulties
of assessing patients with T2DM (Ducat et al., 2014). The clinicians are challenged when
treating the social and emotional difficulties of patients with T2DM in order to develop essential
programmatic interventions (Beverly, Hultgren, Brooks, Ritholz, Abrahamson, & Weinger,
2011). The deficiency of psychological expertise contributes to doctors feeling frustrated,
inadequate and overwhelmed. Understanding how clinicians perceive the severity and
consequences of patients’ psychosocial and mental illness is critical for developing solutions for
these problems (Beverly et al., 2011).
It is critical to integrate psychological screening and treatment into a multidisciplinary
diabetes care team’s work to improve patient and public health outcomes and lessen healthcare
costs. Depression scales that monitor depressive symptoms are practical in clinical diabetes
settings; however, medical professionals do not use an available screening tool. Treatment
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strategies include considering all possible aspects that may contribute to the deterioration of
diabetes comorbidities (Prabhakar, Gupta, Kanade, & Radhakrishnan, 2015). Individuals with
T2DM face the stress of long-term therapy associated with diabetes complications. T2DM
complications include nephropathy, neuropathy, retinopathy, forced lifestyle modifications, and
prolonged hospitalization periods, all of which may contribute to depression (Prabhakar et al.,
2015). Depression is extremely high in patients with T2DM (Siddique, Dogar, Malik, Haider,
Afzal, Cheema, & Azeem, 2014). Diabetes Mellitus (DM) increases among those who take oral
hypoglycemic medications rather than insulin therapy alone. Risk factors for diabetes depression
should be used to educate doctors treating patients with DM (Siddique et al., 2014).
Practical management of depression has improved individuals’ quality of life with T2DM
(Siddique et al., 2014). Treatment strategies for the T2DM population should include the
physician providing a multifaceted approach, considering all possible elements that may add to
the intensification of diabetes comorbidities (Prabhakar et al., 2015). Individuals with T2DM
need continuous monitoring of depression, and once identified, should be required to maintain an
excellent prognosis for diabetes and related complications, including mood disorders like
depression.
The Effects of Peer-Influence Between Clinicians
According to Yang, Lien, and Chou (2014), research revealed that peer-influences are
small between doctors, and stronger among physicians of similar age. Social learning can impact
physician peer-influence as a process in which decision makers collect information by observing
others in their social network (Yang et al., 2014). Through this process, individuals’ behaviors
may change the behaviors of others through exposed information. If social learning occurs, then
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peer-effects can be detected and revealed by changes in an individual’s behavior in response to
that of his or her peers. The peer-effect study found that positive peer-effects are more likely to
exist when peers are of similar age, presumably having similar, comparable experience and
background (Yang et al., 2014). Peer-effects were stronger when physicians have direct
interactions with their colleagues through observations or conversations. It implies that
promoting medical innovations or new scientific findings beneficial to society can be most
effective when the new drug, technology, device, or practice is first introduced (Yang et al.,
2014).
Patient Health Questionnaire (PHQ-9) Scale
The Patient Health Questionnaire (PHQ-9) is a valuable instrument for screening Type 2
Diabetes Mellitus (T2DM) for depression in a primary care setting (Bogner & de Vries, 2010).
The PHQ-9 is a questionnaire that scores each of the nine criteria listed in the Diagnostic and
Statistical Manual of Mental Disorders for depression with scores ranging from 0 to 3 (Locke,
Kirst, & Shultz, 2015). PHQ-9 scale scores indicate a sensitivity of 88% if the score is ≥ 10 and
establishes significant depression. PHQ-9 scale scores of 5, 10, and 20 represent mild to severe
depression (Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., …
Hatcher, 2010). The U.S. Preventive Service Task Force supported using PHQ-9 scales for
depression screening for individuals with T2DM in a primary-care setting (Egede & Ellis, 2010).
Patients can complete the PHQ-9 scale quickly during an office visit. Primary care
physicians can educate ancillary health personnel, such as licensed practical nurses, to administer
the test to T2DM patients (Bogner & de Vries, 2010). The PHQ-9 has a scoring scale to
determine depression severity and assessment for initiating treatment. The PHQ-9 scale is a
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source that can ascertain the effectiveness of depression treatment over time (Acee, 2010).
Individuals with T2DM depression need identification as soon as possible.
Providing the medical community with an understanding of the psychosomatic,
emotional, and social impact of diabetes depression would improve the prognosis for individuals
with T2DM (Speight, Browne, Holmes-Truscott, Hendrieckx, & Pouwer, 2012). Diabetes
promotion and prevention screening focus on reducing diabetes depression and promote positive
health habits. Also, it enhances health and well-being in populations (Nelson & Prilleltensky,
2005). The study conducted by Gois, Dias, Carmo, Duarte, Ferro, Santo, Sousa and Barbosa
(2014) revealed that interpersonal Psychotherapy is a useful tool to treat major depression in
T2DM patients.
Summary
Social change is a continuing process of improving and introducing positive changes.
Continually examining disease symptoms would help to improve the quality of life globally.
Individuals with Type 2 Diabetes Mellitus risk depressive moods resulting in physicians
prescribing a high percentage of antidepressant agents (Whittemore, Melkus, & Grey, 2004).
Individuals with DM are unaware that they have developed depression and are unlikely to seek
medical care for depression (Campayo, de Jonge, Roy, Saz, Camara, Quintanilla, & Lobo,
2010). Publicly, a need persists to increase depression awareness, depression screening, and
initial identification of depression conditions in individuals with T2DM during healthcare
treatment (Schram et al., 2009).
Currently, depression is unrecognized among individuals with diabetes. Beginning a
universal approach to coordinate comprehensive interventions to advance early recognition of
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depression and early initiation of treatment for depression could reduce the worldwide burden of
depression among individuals with diabetes (Egede & Ellis, 2010). A psychosocial assessment
should be part of the regular clinical evaluation of patients with T2DM (Sweileh et al., 2014;
Thour, Das, Schrawat, & Gupta, 2015). Screening patients with T2DM should occur at primary
healthcare clinics to improve patients’ quality of life and decrease adverse outcomes. It is
essential to understand clinicians’ attitudes toward depression screening for individuals with
T2DM and why they may or may not screen for depression.
Chapter 3 addresses the methodology and research design used in this research; Chapter 4
explains the results of this study; and Chapter 5 provides an interpretation of the findings and
outlines implications for social change.
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Chapter 3: Research Method
Introduction
This qualitative descriptive-design study used a case study approach to understand
clinicians’ perceptions of screening patients with T2DM for depression, as well as examine their
behaviors regarding screening. In this chapter, the sample size and eligibility criterion for the
case study is discussed. Also, a description of the significant components of the methodology
used in this analysis includes (a) the research design and rationale, (b) the role of the examiner,
(c) the method, (d) issues of reliability, and (e) a summary. This chapter also includes a
description of the instrumentation and materials to be used.
Research Design and Rationale
A qualitative study is a means to explore and understand the meaning individuals or
groups ascribe to human problems (Creswell, 2014). The inquiry process involves asking
emerging questions and processes; assembling data in a relevant setting; analyzing the data
inductively, building from particulars to general themes; and translating the data’s meaning.
Creswell (2009) recommended that qualitative researchers choose from among the possibilities,
such as a case study. Case studies align with the qualitative design and are widespread across the
health sciences for conducting research. A case study design can focus on a particular subject or
individual case (Creswell, 2009). Case studies are the tactic of inquiry. In this case study, I
comprehensively explored programs, events, activities, and processes of several individuals.
Case studies are limited by time, activity, and the researcher’s ability to collect detailed
information using various data-collection procedures over a sustained period (Creswell, 2007). I
used a case study design to examine the research questions.
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The essential questions of this research were:
1. How do physicians and nurse practitioners describe their attitudes toward screening
T2DM patients for depression?
2. How do physicians and nurse practitioners describe their T2DM depression –
screening behaviors?
3. How do physicians and nurse practitioners describe their perceptions of whether their
peers support screening the T2DM patient for depression?
The following are an example of research questions that were asked during the interview:
1. Do you talk to your Type 2 Diabetic patients about depression?
a) If yes, please describe your process for talking with your patients.
b) If no, please describe why you did not discuss depression with your patients.
2. Do you screen T2DM patients for depression?
a) If yes, please describe your process for screening T2DM patients for depression.
b) If no, please describe why you do not screen T2DM patients for depression.
3. What do you think are the advantages and disadvantages of screening T2DM patients
for depression?
4. Do you think your peers would approve of screening T2DM patients for depression?
a) Describe what you think your peers think about screening T2DM patients for
depression.
The case study research uses a qualitative approach (Creswell, 2007). Researchers
explore a limited system (a case) or multiple systems (cases) over time through detailed, in-depth
data accruing from multiple sources and report a case description. Social scientists,
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anthropologists, and sociologists use a case study approach, and it is a simplified methodology in
psychology and medicine when analyzing specific problems (Creswell, 2007). The rationale for
selecting this design relates to this study’s purpose: understanding clinicians’ perceptions of
screening patients with T2DM for depression, as well as examining their behaviors regarding
testing for depression (Ajzen & Fishbein, 1980).
Stake’s (2006) most recent book on multiple case study analysis presents a step-by-step
approach and illustrates numerous case studies in Ukraine, Slovakia, and Romania. A case study
is a good plan when the inquirer has an identifiable question. The case study has boundaries and
provides an in-depth understanding of the case or a comparison of several cases (Creswell,
2014). According to Creswell (2007), case study research should include no more than four or
five case studies in a single study. This number has offered ample opportunity to recognize
themes of the cases as well as to conduct cross-case theme analysis (Creswell, 2007). Case
studies are standard in the medical field to investigate or search for understanding of a group of
medical professionals’ behavior and psychosocial impact.
Role of the Researcher
A qualitative study requires a small number of individuals or situations that preserve the
individuality of each of these in their analyses, rather than collecting data from large samples and
aggregating the data across individuals or situations. My role as a researcher was to understand
and explore cases for T2DM depression. I was required to ensure that the interviews were
conducted thoroughly. It was my responsibility to ensure that participants understood the
investigation questions, felt comfortable discussing the study, and were encouraged to exhaust
questions so that sufficient data emerged for meaningful analysis (Creswell, 2014). Further, my
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role was to eliminate any situation of conflict of interest. Also, it was my responsibility to ensure
that the interview process was unbiased. To the best of my ability, I conducted and analyzed the
study without any prejudgment or preconception.
My role as the researcher was to determine if the participants were appropriate to
participate in the study by reviewing the participant’s medical practice history. The participant
must have had a state medical license and specialty medical license, treat T2DM subjects, and
had been in practice for 5 years. Also, all data were collected from the participants in their
natural environment. In the researcher’s role, I viewed myself as a human instrument, gathering
data from participants through interviews, tape recordings, and field notes. Data were collected
by asking participants interview questions about their clinic and patient population. I recorded
participants’ answers during the interview sessions, and after data collection, I analyzed
participants’ answers.
Methodology
The study participant recruitment took place in Saint Louis, Missouri, and the following
cities in Mississippi: Charleston, Horn Lake, Calhoun City, Pora, Hernadoi, and Pope. Doctors
and nurse practitioners had agreed to confidentiality prior to the study. Participants had ample
time to address protocol questions. I obtained protocol approval from Walden University’s
Institutional Review Board (IRB) before the study began, and I maintained current documents
and fulfilled all IRB requests during the study.
Recruitment began by contacting medical schools and the medical society, reviewing the
phone book and the internet in Saint Louis, Missouri, Charleston, Horn Lake, Calhoun City,
Pora, Hernado, and Pope, Mississippi to obtain a list of clinicians’ contact information. I sent a
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letter by email to introduce the study to physicians and nurse practitioners requesting their
participation in the study. Advertising of the study did not occur, I recruited doctors and nurse
practitioners through email and telephone contact. All physicians and nurse practitioners’ legal
qualifications were verified thoroughly by the Missouri and Mississippi Medical-License Board.
The Missouri and Mississippi board of registration has a list of licensed clinicians, including
their license number, license expiration date, primary business address, board certification, and
professional school.
Recruited participants were expected to speak and read proficiently in English.
Participants consisted of five to ten doctors or nurse practitioners with a medical license.
According to Creswell (2007), case studies require five to ten cases for a single research study.
Doctors and nurse practitioners were required to have at least 5 years of experience and actively
be treating patients diagnosed with T2DM. I collected the doctors’ and nurse practitioners’
demographics and education level during the interviews for sample-description purposes only.
All eligible clinicians who gave informed consent were the participants interviewed for this
study. I explained the participants’ rights during the informed-consent process. Doctors and
nurse practitioners had the right to refuse participation without any penalty. Participants verbally
consented prior to completing any study procedures or interviews. The Interview Questions
Guide directed interviews so that participants discussed matters related to screening patients with
T2DM for depression. I interviewed 8 clinicians for this T2DM study, and this sample size
achieved saturation of themes. Saturation is achieved once the interviewer has no new data to
collect (Creswell, 2014).
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Instrumentation
The qualitative research instrumentation used in this study included interview questions
and observations. The open-ended interview questions allow me to focus on the individual and
provide the opportunity for a detailed investigation of participants’ perspectives and an in-depth
understanding of the personal context within which the investigation was conducted (Schensul,
Schensul, & LeCompte, 1999). Interviews were conducted via telephone or privately online
using email. I asked all participants for one hour of their time to answer open-ended questions.
An Interview Guide (Appendix A) was used to manage the flow of the interview. The questions
in the Interview Guide reflect the literature gap and focus on the objectives of the study. The
Interview Guide helped me pursue the same primary lines of inquiry with each participant. Focus
groups were not considered for this study because they do not focus on the individual, and they
employ less opportunity for the generation of individual accounts.
Procedures
Study research questions were addressed through open-ended, and in-depth interview
questions. Questions were administered to informants via telephone in the participant’s office or
the setting of choice. The primary data source was collecting a narrative recording of 8
participants. Before each interview, participants were requested to agree to a digital record of the
conversation. I interviewed participants via telephone and used email for those participants who
cannot meet with me in person. Through email, I communicated with participants in writing. The
email allowed me to save written conversations to a new external drive.
I sent qualified and interested participants information about the study, participation
criteria, the informed-consent form, and the Interview Question Guide. Participants provided
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written consent during email or verbal consent during telephone interviews. I asked participants
to provide compatible days and times for scheduling a 60 minutes telephone interview and gave
basic instructions on how to access Skype if they did not have it installed on their computers.
Participants could opt to have a Skype interview instead of a telephone interview.
To assist participants, I sent the interview questions prior to the interview. The interview
(see Appendix A) began by asking, “Do you treat patients with T2DM in your practice?” Next, I
asked participants about their treatment and screening behaviors. The complete interview
protocol appears in Appendix A. I developed the interview questions after referencing work by
Ajzen and Fishbein (1980). The interview questions were not pilot tested.
All study-related data and material will be maintained for a minimum of 5 years after
completing the research. I identified each participant by their name and I randomly assigned each
participant a number to conceal their identity. I recorded all participants’ telephone conversations
during the interview. The participants’ information collected was summarized for the participant
during the interview to agree or disagree with the information and I transcribed the interview
summary afterward for analysis. I sent a $10.00 Starbucks gift card thanking respondents for
participating approximately five to ten days after each interview. Member checking was used to
check the accuracy of the transcriptions.
Data-Analysis
The data-analysis techniques included describing, interpreting, drawing conclusions, and
determining significance. The emergence of findings through my interaction with and
involvement in the data results in the form of patterns, themes, or categories that emerge from
the data. The initial stages involve open coding, which means that I am open to what the data is
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saying without bringing any preexisting codes. The participants’ summary and digital record of
the conversation was transcribed before the data were analyzed. Open coding emphasizes
recognizing any patterns that emerge from the data. The coding process involves reviewing the
data, applying short-hand labels to passages of data, or other items for more natural organization
and recognition.
The next step in case study data analysis was comparing across various themes that have
emerged from the data as well as making comparisons across cases; I compared themes as they
emerge. I used the data to create detailed descriptions of clinicians’ screening or not screening
patients with T2DM for depression. I used NVivo to analyze the data for the case study. NVivo
is software that supports qualitative and mixed-method research. NVivo is a computer program
designed to help organize and discover a comprehension of unstructured or qualitative data like
interviews and open-ended survey responses. NVivo analyzes small or large volumes of data and
is available for Windows PCs. NVivo helps researchers analyze and manage qualitative data,
allowing for the researchers to manipulate the data, codes, and categories in the data (Creswell,
2007).
Manually analyzing data could be time-consuming, challenging researchers to manage
and navigate the process. Completing this kind of research without software can make it
challenging to discover connections in the data and find new insights. I managed data analysis
using NVivo software, identifying themes that describe if and why clinicians screen for
depression with attention on how well the topics align with TRA.
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Issues of Trustworthiness
The issues of trustworthiness were established by credibility, transferability,
dependability, and confirmability (Rudestam & Newton, 2007). Researchers use this process to
determine whether the participants report accurate information. Credibility in qualitative research
corresponds with internal validity. The study findings’ credibility requires sufficient time with
the participants to check for distortions, explore the participants’ experience, and lack details.
The extended time was spent to help develop an in-depth understanding of the study, which can
convey details about the site and the people that lend credibility to the narrative description.
Transferability in qualitative research corresponds with external validity (Morrow, 2005).
External validity would allow the researcher to duplicate the original study design process and
apply it to other studies. The qualitative study was a description of a relatively small number of
participants within the context of a specific setting. The study participants’ qualitative
descriptions or settings were sufficient and can be applied in a similar setting. Generalization is
the reader’s task rather than the author of qualitative studies (Rudestam & Newton, 2007).
Dependability in qualitative research corresponds with reliability (Morrow, 2005).
Surveys and interviews were part of the internal validity which obtains information from the
participants (Rudestam & Newton, 2007). Internal validity includes scientific observations and
measurements (Rudestam & Newton, 2007). Dependability would allow the results of the survey
to be duplicated.
Confirmability in qualitative research corresponds with objectivity (Rudestam & Newton,
2007). Purposeful sampling has a means by which qualitative researchers increase credibility. I
utilized purposeful sampling by requiring participants to meet specific criteria. Confirmability
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was enhanced by using original data; making it available to interested readers, and keeping an
ongoing journal of the experience. I provided questions, interpretive processes, document
activities, and discussion with participants to interest readers (Rudestam & Newton, 2007).
Ethical
The ethical protection includes the participants’ rights, risks, and confidential information
about the subject’s study results (Creswell, 2014). The rights, risks, and confidentiality of the
participants were explained during the informed consent process. The participants were notified
of their rights during the informed consent progress. The participants had ample time for
questions and answers about the study. The participants’ risks include social, economic, physical,
and psychological harm, which could occur during or after the study. The social risk could
include jeopardizing the individuals’ reputation and social standing.
Summary
This section discussed data-collection and analysis protocols for the study. I presented a
brief discussion of the qualitative methodology. My role as the researcher which was to
interview participants, record answers, and analyze the data. The segment on participants
contained the required criteria for participation and presented the advantages and disadvantages
of internet use for data collection. Sections on data collection and analysis discussed how data
were obtained and used, including activities to enhance rigor and legitimacy. Chapter 4 presents
the research findings.
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Chapter 4: Results
Introduction
This qualitative case study explored attitudes, behaviors, and perceptions of physicians and
nurse practitioners treating individuals with T2DM. Specifically, the purpose of the study was to
explore the physicians’ and nurse practitioners’ screening of patients with T2DM for depression,
as well as their thoughts and behaviors regarding screening. Through a systematic sampling
methodology, ten participants were interviewed. The following research questions guided this
study:
Research Question 1: How do clinicians describe their attitudes toward screening T2DM
patients for depression?
Research Question 2: How do clinicians describe their T2DM depression –screening
behaviors?
Research Question 3: How do clinicians describe their perceptions of whether their peers
support screening the T2DM patient for depression?
In this chapter, I discuss the setting, demographics, data collection, data analysis, and
results. The data analysis subsection includes a description of the 10 codes that emerged from the
data and contributed to the thematic analysis. I then discuss evidence of trustworthiness, which
includes addressing credibility, transferability, dependability, and confirmability of the data.
Last, I presented the themes that address each research question.
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Setting
After obtaining IRB approval (#10-03-18-0071106), I contacted clinicians through their
publicly available hospital email or telephone number to solicit their participation. Additional
participants were obtained through the snowball method.
After ascertaining that each participant met the eligibility criteria, including that of
specializing in treatment of T2DM, the study interview took place using the interview questions
presented in Appendix A and discussed in Chapter 3. Follow-up questions were asked in
interviews if necessary to better understand what the participant raised. The interviews took
place in a quiet space with a closed door to allow for privacy and no interruptions. No personal
or organizational conditions influenced participants during the interview at the time of the study.
Demographics
A total of 11 participants were recruited to the study; however, three of the participants recruited
were not included due to insufficient years of experience treating individuals with T2DM and
thus not meeting study eligibility. Three doctors and five nurse practitioners took part in the
research. The participants all spoke English, had 5 or more years of experience treating
individuals with T2DM, and had a medical license in the United States. Participants were
between the ages of 30 to 70, with one being between the ages of 30 to 39; four were between
the ages of 40 to 49, and three were between the ages of 60 to 69. Six of the participants were
female. All participants were married, except one, who was widowed. Three participants were
doctors of medicine, and five participants were nurse practitioners (see Table 1).
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Table 1
Demographic Information on the Sample
Name

Sex

Marital
Status

Education

Participant 1

Age
Range,
in Years
60-70

Male

Married

Endocrinologist

20+

Unknown

Participant 2

40-50

Female

Married

Internal Medicine

15+

41+

Participant 3

40-50

Female

Married

NP general medicine

20+

31-40

Participant 4

60-70

Male

Married

Endocrinologist

20+

Unknown

Participant 5

30-40

Female

Married

NP general medicine

10+

21-30

Participant 6

40-50

Female

Married

NP family medicine

10+

06-10

Participant 7

60-70

Female Widowed NP family medicine

05

21-30

Participant 8

40-50

Female

20+

21-30

Married

NP general medicine

Years of Patients per
Experience
Day

Data Collection
I collected data from 8 medical professionals using the method described in Chapter 3
with some approved revision, explained below. Each participant consented and had ample time
to ask questions if needed. I collected demographic and descriptive information during the
interview from physicians and nurse practitioners. It included age range, education, marital
status, type of physician or nurse practitioner, office setting, years of experience treating T2DM
patients, and number of T2DM patients seen in a day (see Appendix D). I interviewed each
participant 30-60 minutes one time and summarized their responses during the discussion. The
interviews took place in a quiet space of the participant’s choice with a closed door to ensure
privacy for the data collected through telephone conversations or email correspondence.
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Participants’ interviews were recorded on a digital recording device, and hand-written notes were
also taken during the interview. The digital recording and notes were checked after the
transcribed data were analyzed to establish credibility. No unusual circumstances arose during
data collection interviews.
The data collection differed from the original plan in Chapter 3 to include a nationwide
search for participants, and the search was extended to include nurse practitioners. The original
data collection plan only included Missouri physicians. However, due to the inability to recruit a
sufficient number of physicians for the study in Missouri, I submitted a request form to the IRB
for recruitment to be extended nationwide and to include nurse practitioners in addition to
physicians. The original research questions were adjusted to include both physicians and nurse
practitioners.
Data Analysis
In this study, I captured the perceptions and experiences of participants screening T2DM
patients for depression. Once the interviews were complete, I read the transcribed data multiple
times while listening to the digital recording to ensure accuracy and began the process of
identifying codes and themes that emerged from the data. I put the information into NVivo,
arranging the data to establish codes and themes. The data analysis strategy included the steps I
outlined in Chapter 3.
First, I recorded and transcribed each interview. I highlighted significant statements of
how participants described their experiences and entered the data information into NVivo. The
next step included developing codes and themes. A written account of what participants
experienced from their descriptions of treating individuals with T2DM depression was
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composed. A written summary of the position or opinion of participants’ experiences treating an
individual with T2DM depression was developed into themes. The following are the codes that
emerged, along with short definitions and examples of direct statements taken from the
interviews with study participants that demonstrated each code meaning. Ten codes emerged
from the data includes.
1. Sleep Deprivation supported by 10% of the participant.
2. Scale Patient Health Questionnaire 2 Item (PHQ-2) supported by 10% of the
participant.
3. Scale Patient Health Questionnaire 9 Item (PHQ-9) supported by 20% of participants.
4. T2DM Depression Screening supported 20% of participants.
5. Diabetic Diet supported by 10% participants.
6. T2DM Depression Non-Screening supported by 20% participants.
7. Peer Approval supported by 50% of participants.
8. Advantage of Depression Screening supported by 20% of participants.
9. Focus supported by 40% of participants.
10. Standard of Care supported by 40% of the participants.
Three themes emerged from the codes to answer research questions.
Code 1: Sleep Deprivation
Sleep deprivation emerged in the data referring to any sleep deprivation or disruptions
due to T2DM. The sleep deprivation was described as symptoms of sleep fragmentation and
often came up in the conversation about depression. Participant 1 contributed the sleep
deprivation code.
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Code 2: Scale Patient Health Questionnaire 2 Item (PHQ-2)
The code PHQ-2 emerged when a participant described the screening process of
individuals with T2DM. The PHQ-2 is a scale that measured the frequency of an individual’s
depressed mood over the past 2 weeks. The code PHQ-2 refers to tools used to evaluate T2DM
patients for depression during a clinic visit. Participant 2 contributed the PHQ-2 code.
Code 3: Scale Patient Health Questionnaire 9 Item (PHQ-9)
The code PHQ-9 emerged when a participant described the screening process of
individuals with T2DM. The PHQ-9 is a scale that screens, diagnoses, monitors, and measures
the severity of an individual depressed mood. Participants 2 and 8 contributed to the PHQ-9
code.
Code 4: T2DM Depression Screening
The code T2DM Depression Screening emerged when a participant described any
screening process of individuals with T2DM. The T2DM Depression Screening code was
described as mood and mental changes causing depression in individuals with T2DM.
Participants 2 and 8 contributed to the T2DM depression screening code.
Code 5: Diabetic Diet
The code Diabetic Diet emerged when a participant described the diet, eating, or anything
related to a dietary plan in T2DM patients. Participant 3 contributed the T2DM diabetic diet
code.
Code 6: T2DM Depression Non-Screening
The code T2DM Depression Non-Screening emerged when a participant described the
non-screening process of individuals with T2DM. The code of T2DM Depression Non-Screening
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was defined as deliberate non-screening of depression in patients with T2DM. Participants 2 and
8 contributed the T2DM depression non-screening code.
Code 7: Peer Approval
The code Peer Approval emerged when the participants talked about their perception of
what their peers thought about screening or peers’ behaviors regarding screening. It was a
perceived positive appraisal of screening by their peers. Participants 2, 5, 6, 7, and 8 contributed
to the T2DM peer approval code.
Code 8: Advantage of Depression Screening
The code advantage of depression screening emerged when participants described the
benefits of screening for depression in their patients. Participants 2 and 8 contributed the
advantage of the depression screening code.
Code 9: Focus
The code Focus emerged when participants described their emphasis on treating the
patient’s diabetes. Clinicians were not focusing on the comorbidity of patient diabetes disease.
Participants 3 and 5 contributed the focus code.
Code 10: Standard of Care
The code Standard of Care emerged when the participants described a standard of care
for T2DM patients. Participants 2 and 8 contributed the T2DM standard of care code.
The codes of Focus, Standard of Care, and Peer Approval, rolled over into the theme
category to answer the research questions. Overall, three themes emerged from the data to
explain physicians’ and nurse practitioners’ experiences of screening T2DM patients for
depression. These themes included: 1) clinicians’ focus on treating the physical disease of
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diabetes and not the comorbidity of the disease, 2) T2DM depression screening standard practice
or part of the clinical assessment process, and 3) peer’s approval of T2DM depression screening.
Each theme is discussed in conjunction with the relevant research question below.
Results for Research Question 1
Research Question 1 asked: How do physicians and nurse practitioners describe their
attitudes toward screening T2DM patients for depression? One theme emerged to answer this
question. The first and most dominant theme that emerged from interviews and the theme that
provides data for this research question was that physicians and nurse practitioners believed their
focus as a clinician was to treat the physical disease of diabetes, with little attention given to
psychological or social conditions. Although clinicians acknowledged depression as comorbidity
of diabetes, clinicians talked extensively about treating T2DM and their primary focus on the
patient's physical disease.
It was evident from four clinicians’ statements that the physical illness was the focus of
most of their time with their patients. For example, when discussing what they focused on
regarding treatment, clinicians often discussed diet. Participant 3 reported that “patients are
encouraged to eat less rice, less bread, and encourage healthier foods (for example, green leafy
food) and exercise.” Furthermore, participant 5 stated, “patients are encouraged to lose weight
and not to use food as a comfort.” Some patients were prescribed diabetic medication because of
weight gain and serum blood sugar increase. In discussing their attitudes towards screening
T2DM patients for depression, it was clear that participants primarily focused on diabetes
physical treatment with little attention to other conditions.

55
It should be noted that interviews revealed that clinicians were aware that depression was
a comorbidity of individuals with T2DM. Most of the clinicians also reported that they had a
standard care protocol for screening T2DM patients for depression as part of the routine visit.
However, according to the clinicians' statement, depression was not a primary focus of treating
patients with T2DM depression, but rather the clinicians focused on physically controlling
T2DM patients' blood sugar.
Therefore, a dominant theme of the interviews was the focus on the physical treatment of
depression, and while it should be noted that most of the physicians and nurse practitioners did
screen for depression, they did not consider it a focus of their attention. They were aware of
depression’s comorbidity with T2DM and also acknowledged its importance. However, they did
not perceive it to be their focus. The participants’ screening behaviors are noted in the
description of findings under Research Question 2.
Results for Research Question 2
Research Question 2 asked: How do physicians and nurse practitioners describe their
T2DM depression –screening behaviors? A standard of care theme emerged to answer this
question. The second and most dominant theme that emerged from interviews, and the theme that
answered this research question, is that physicians and nurse practitioners believed their standard
of care addresses depression screening of patients’ T2DM during routine diabetes checkup.
Although clinicians acknowledged depression as a comorbidity of diabetes and did have a
screening protocol as part of routine visits, few clinicians talked about depression with their
T2DM patients. For example, Participant 2 noted that the PHQ-2 is used to evaluate patient
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mental health during the routine diabetic examination in their office. If [the participant] identifies
a patient with depression, then the patient is treated with medication for the depression.
Additionally, participant 4 stated that they provide “a brief discussion with T2DM
patients about depression”. However, they went on to say that further details would be explored,
if necessary, with little specificity of what that looks like. Participant 6 stated that “asking the
T2DM patients if they are feeling unhappy is how patients are evaluated for depression.”
Participant 1 described that “the depression screening process for T2DM patients occurs during
annual checkups by administering the PHQ-9 scale if the patients are over 65 years of age. If the
T2DM patient has a depression diagnosis, then the primary care physician treats the patient for
T2DM and depression.”
From their discussion of depression screening behavior of T2DM patients for depression,
it was clear that participants’ standard of care technically addresses an individual’s mental status
with diabetes, but with little focus provided or developed. This reinforces the theme focus found
in Research Question1 in which clinicians’ focus is on physical disease management.
Results for Research Question 3
Research Question 3 asked: How do physicians and nurse practitioners describe their
perceptions of whether their peers support screening the T2DM patient for depression? The third
theme that emerged from interviews is that physicians believed their peers would support
screening T2DM patients for depression. According to Participant 2, “[their] peers would support
screening T2DM for depression and would say that treating the patient’s mental health was
essential.” Participant 2 also stated that, “the American College of Medicine recommends
screening patients for depression for chronic illness.” Furthermore, Participant 3 stated, “if
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[their] peers are screening T2DM for depression, [their] clinic would evaluate if that was
something to incorporate into [their] clinic”. In their discussion, Participants 2, 5, 6, 7, and 8
stated that they understood the benefit of screening T2DM for depression, believed it would be
widely supported, and acknowledged that early detection of depression would allow for
treatment of depression sooner rather than later. Despite a keen awareness of peer and
professional organization support for screening for depression in T2DM, with ample evidence
for its necessity, clinicians continued to focus on being responsible for managing the physical
side of the disease.
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Table 2
Theme Findings
__
Participants
1, 3, 4, 5

Themes
Focus

2, 6, 7, 8

Standard of care

2, 5, 6, 7, 8

Peers approval

Research questions
How do physicians and nurse
practitioners describe their
attitudes toward screening T2DM
patients for depression? Although
clinicians acknowledged
depression as a comorbidity of
diabetes, clinicians talked
extensively about their focus on
treating T2DM being primarily
the patient's physical disease.
How do physicians and nurse
practitioners describe their T2DM
depression –screening behaviors?
From their discussion of
depression screening behavior of
T2DM patients for depression, it
was clear that participants’
standard of care technically
addresses an individual’s mental
status with diabetes, but with little
focus provided or developed.
How do physicians and nurse
practitioners describe their
perceptions of whether their peers
support screening the T2DM
patient for depression? Despite a
keen awareness of peer and
professional organization support
for screening for depression in
T2DM, with ample evidence for
its necessity, clinicians continued
to focus on being responsible for
managing the physical side of the
disease.

_____________________________________________________________________
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Evidence of Trustworthiness
Credibility
As noted previously in the methods section of Chapter 3, quality research involves
validation strategies. According to Creswell (2007), credibility, transferability, dependability,
and confirmability, are essential to helping solidify the study’s documentation accuracy. This
qualitative case research study aimed to understand participants’ attitudes, behaviors, and
perceptions of screening patients with T2DM for depression. The participant is best able to
determine credibility of the data that they have contributed. Thus, one of the best ways to
establish credibility is to have participants check the data for accuracy. I provided a summation
of the participant responses to the interview questions during the discussion, and the participants
were allowed to agree or ensure correctness, which was the most significant method to verify
credibility, according to Creswell (2007). This study further addressed reliability of the data
through the saturation in the information received.
Transferability
Transferability was addressed in this study through purposeful sampling. It was further
addressed through the detailed description of the population and setting. Purposeful sampling is a
technique widely used in qualitative research to identify and select participants for the most
effective use of limited resources. Although this study utilized purposeful sampling by requiring
participants to meet specific criteria, the results may apply to other studies (Rudestam & Newton,
2007). This qualitative research presented detailed description of the participants, and the study
background was sufficient to apply to a similar environment.
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Dependability
Reliability in qualitative research can be seen as dependability in qualitative research
(Rudestam & Newton, 2007). This research established dependability through the use of auditory
taped interviews. I reviewed the transcribed audiotapes numerous times to maintain accuracy in
conjunction with detailed notes of each interview.
Confirmability
Confirmability is the degree to which others can confirm the results. Confirmability was
easily established by documenting the procedures for checking and rechecking the data. I
summarized the participants’ results during the interview to recheck accounts of their experience.
Though inter coding reliability may be established through use of two or more coders, this study
used intra coding with only me. I intra coded systematically to ensure all coding was consistent
(Creswell, 2007).
Summary
This chapter provided the original study results that examined physicians’ and nurse
practitioners’ attitudes, behaviors, and perceptions, regarding screening T2DM patients for
depression through three research questions. The results led to 10 codes and 3 theme findings.
The overall results indicated that participants’ varied in treating T2DM patients. Peer influence
on screening patients for T2DM, while reported to be positive, appeared to have little effect on
clinicians. The medical office process appeared to regulate whether individuals with T2DM were
screened for depression by the clinicians. The clinicians were aware that individuals with T2DM
could develop depression; however, the majority of the clinicians’ focus in treatment appeared to
be on the patients’ physical management of disease through diet regimen, medication, and
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exercise. In Chapter 5, the findings, implications, and recommendations for practice and research
are presented.
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Chapter 5: Discussion, Conclusions and Recommendations
Introduction
This qualitative case study was conducted to examine clinicians’ attitudes, behaviors, and
perceptions in screening individuals with T2DM for depression. A qualitative case study design
was employed, that allowed for physicians and nurse practitioners to describe their process for
screening patients with T2DM for depression. While conducting a review of the literature, I
found limited research that focused on individuals with T2DM and depression. This research
study was driven by that lack of research and the need to examine attitudes and behaviors of
clinicians towards screening T2DM patients for depression. Results from this study could add to
the body of knowledge relating to clinicians and T2DM depression screening.
In this chapter, I discuss the analysis and interpretation of the findings. I also discuss
study limitations, recommendations for future research, and implications for social change.
Clinicians were asked three research questions pertaining to their processes for screening
T2DM patients for depression. The research questions were as follows: 1) How do clinicians
describe their attitudes toward screening T2DM patients for depression? Based on participants’
responses, I determined that three participants screened patients for T2DM depression as this was
part of the clinic’s health checkup process; however, the majority of clinicians did not screen
T2DM patients for depression. 2) How do clinicians describe their T2DM depression screening
behaviors? Most of the clinicians’ treatment focus appeared to be on the patients’ physical
management of their disease through diet regimen, medication, and exercise. I also found that
most participants did not screen T2DM patients for depression or speak with the patient about
depression being a comorbidity of diabetes. Findings further showed that clinicians were aware
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that individuals with T2DM could develop depression. 3) How do clinicians describe their
perceptions of whether their peers support screening T2DM patient for depression? While peer
influence on screening patients with T2DM for depression reported to be positive, it appeared to
have little effect on clinician’s behavior or attitudes towards screening T2DM patience’s for
depression.
This qualitative study included eight participants that I interviewed for approximately 30
to 60 minutes each. Based on the answers to the three research questions, four out of the eight
participants felt they should start screening T2DM patients for depression. The four stated that
perhaps depression screening should be added to their clinic screening process for T2DM
patients. Results led to 10 codes and three theme findings; the overall results indicated that
participants’ experience varies when treating T2DM patients.
Interpretations of Finding
TRA was used as a theoretical lens to explore clinicians’ behaviors related to screening
T2DM individuals for depression. Three research questions were created to explore phenomenon
experiences of clinicians’ processes of screening T2DM patients for depression. From the
interview data, 10 codes and three themes emerged. The overall results indicated that
participants’ attitudes varied toward T2DM depression screening.
TRA served as the theoretical framework for this study. Using TRA as a theoretical lens,
this study explored clinicians’ depression screening behaviors, attitudes toward screening, and
perceptions of social peer approval toward screening patients with T2DM for depression. The
study results led to 10 codes and three theme findings. The three themes emerged from the data
to explain physicians’ and nurse practitioners’ experience as it relates to screening T2DM
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patients for depression. The first theme included clinicians’ focus on treating the physical disease
of diabetes and not the comorbidity (depression) of the disease, the second theme was T2DM
depression screening standards of care are part of the clinical assessment process, and the final
theme was that peers approved of T2DM depression screening.
The medical office process appeared to regulate if individuals with T2DM were screened
for depression by the clinicians. The clinicians are aware that individuals with T2DM could
develop depression; however, most of the clinicians’ focus on treatment appeared to be on the
patients’ physical management of disease through diet regimen, medication, and exercise.
Results revealed that clinicians focus primarily on treating individuals with T2DM physical
disease and ignore T2DM depression. The four clinicians lacking screening individuals for
T2DM depression could result in clinicians not providing the patient with comprehensive care
for T2DM diabetes. Providing patients with T2DM, a psychological evaluation for depression,
and a physical treatment plan could improve this population's overall health.
I also used TRA as a theoretical lens to explore clinicians’ attitudes toward screening
T2DM patients for depression. Results revealed that some physicians and nurse practitioners
have a T2DM standard of care procedure that includes screening individuals with diabetes for
depression during routine diabetes checkups. Further, clinicians who acknowledged that
depression is a comorbidity of diabetes have a screening protocol as part of routine visits and
discuss depression with their T2DM patients during their routine checkups. By screening T2DM
patients for depression, the physician and nurse practitioners provide the patient with a
comprehensive care plan for managing T2DM.
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TRA was also used as a theoretical lens to explored clinicians’ perceptions of social peer
approval toward screening patients with T2DM for depression. Results revealed that clinicians
believe their peers would support screening T2DM patients for depression. Results indicated that
clinicians' peers supported screening T2DM patients for depression and felt that treating the
patient's mental health was essential. The benefit of screening T2DM patients for depression was
widely supported, and it was acknowledged that early detection of depression would allow for
depression treatment sooner. Despite a keen awareness of peer and professional organization
support for screening for depression in T2DM patients and with strong evidence for its necessity,
clinicians continued to focus on their responsibilities of managing the physical side of the
disease. Even those clinicians are aware that individuals with T2DM could develop depression.
Most clinicians focus on the patients’ physical management of disease because that is the
standard of care for diabetic patients.
Limitations of this Study
This research study was limited to a focus on clinicians screening of patients with T2DM
for depression. This study results do not expand to other chronic diseases. Another limitation was
that if clinicians understand T2DM depression exists and if they included screening patients with
T2DM for depression. The completion of this study did not provide clear evident that clinicians
integrated T2DM screening to evaluate depression for diabetic patients; thus, not knowing if
screening T2DM patients was integrated into the daily clinical practice could present as a
possible potential weakness of this study.
The study’s final limitation was that data collected from a small group may not yield an
accurate picture of the present population, and generalization of the results may be ambiguous
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due to the limited number of interviewees. The original study included only eight participants
recruited from the Saint Louis Missouri, Charleston Horn Lake, Calhoun City, Pora, Hernado,
and Pope Mississippi of the United States. Due to the small sample, the data may not be
generalized to other populations in other regions, possibly limiting transferability.
Recommendations for Research
One of the first recommendations for further study would be for researchers to design a
study with various experience treating T2DM patients for depression. This study was designed to
recruit participants with a level of experience treating T2DM patients for five years or greater.
Conducting the same research with clinicians who are new to treating T2DM patients or who
have only been treating T2DM patients for less than five years, may yield different results as
new clinician may have a different view point or may have gain additional knowledge that may
not have been provided to the participants who met the criteria for this present study.
A second recommendation for future research is to seek participants from different
geographical areas throughout the United States. This present study recruited participants from
Saint Louis, Missouri, Charleston, Horn Lake, Calhoun City, Pora, Hernado, and Pope,
Mississippi. Conducting this study over different geographical areas across the United States
may results in different results as different states may have different guidelines and attitudes as it
relates to screening forT2DM depression.
Implications
Based on the findings from this study, there are several implications for social change. A
potential implication for social change could be the benefit to individuals living with T2DM
being diagnosed earlier and receiving treatment that could result in limiting the effects of
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depression. An individual living with T2DM would be diagnosed with depression, and treatment
would begin earlier than later in the disease progression. Another implication clinician focusing
on T2DM depression would be an enormous potential impact for positive social change for the
individual and the medical community level. If clinicians emphasized screening individuals with
T2DM for depression, the result could lead to early depression treatment. An additional
implementation for social change could be the implementation of T2DM depression screening
instruction for future clinicians seeking to serve this population.
Conclusion
This research study revealed that every participant believed it is beneficial to create a
standard practice of screening T2DM parents for depression. Results showed that four of the
participants screen their T2DM patients for depression and provide treatment when necessary.
Results further revealed that peers approved of depression screening and saw this as an important
additional to treatment planning for T2DM patients. This study extended the body of knowledge
concerning clinicians’ phenomenon experience and lends insight into the process of depression
screening perspective on the role of clinicians. The potential implication for social change on the
individual and medical community level is that clinicians will more rapidly provide information
to patients around T2DM depression and develop a process to provide treatment plans that
address depression during the treatment of patient’s living with diabetes in an effort to provide
overall mental and physical health success.
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Appendix A: Interview Questions
1. Do you talk to your Type 2 Diabetic patients about depression?
a) If yes, please describe your process for talking with your patients.
b) If no, please describe why you did not discuss depression with your patients.
2. Do you screen T2DM patients for depression?
a) If yes, please describe your process for screening T2DM patients for depression.
b) If no, please describe why you do not screen T2DM patients for depression.
3. What do you think the advantage and disadvantage of screening T2DM patients for
depression?
4. Do you think your peers would approve of screening T2DM patients for depression?
a) Describe what you think your peers think about screening T2DM patients for
depression.

87
Appendix B: Confidentiality Agreement

Name of Signer:
During the course of my activity in collecting data for this research: Vickie Bland will have
access to information, which is confidential and should not be disclosed. I acknowledge that
the information must remain confidential, and that improper disclosure of confidential
information can be damaging to the participant.
By signing this Confidentiality Agreement, I acknowledge and agree that:
1. I will not disclose or discuss any confidential information with others, including friends or
family.
2. I will not in any way divulge, copy, release, sell, loan, alter or destroy any confidential
information except as properly authorized.
3. I will not discuss confidential information where others can overhear the conversation. I
understand that it is not acceptable to discuss confidential information even if the
participant’s name is not used.
4. I will not make any unauthorized transmissions, inquiries, modification or purging of
confidential information.
5. I agree that my obligations under this agreement will continue after termination of the job that
I will perform.
6. I understand that violation of this agreement will have legal implications.
7. I will only access or use systems or devices I am officially authorized to access, and I will not
demonstrate the operation or function of systems or devices to unauthorized individuals.
Signing this document, I acknowledge that I have read the agreement and I agree to comply with
all the terms and conditions stated above.

Signature:

Date:
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Appendix C: Inclusion and Exclusion

Inclusion Criteria:
•

Practice in Family Medical, Internal Medicine or Endocrinologist

•

Treat T2DM patients

•

English speaking

•

Medical License in the United States

•

Five Years of Experience in the field

Exclusion Criteria:
•

Do not have a medical license in the United States

89
Appendix D: Demographic Information
1. Demographics
a. Age (Date of Birth)
b. Gender
i.

Male

ii.

Female

c. Marital status
i.

Married

ii.

Widowed

iii.

Divorced

iv.

Single

d. Education
i.

Bachelor Degree,

ii.

Doctor of Medicine (MD)

iii.

Doctor of Osteopathic Medicine (DO)

e. Type of Doctor
i.

Medical practitioner

ii.

General practitioner

iii.

Internists

iv.

Endocrinologist

v.

Family Physicians

f. Office setting

90
i.

Private Clinic

ii.

Hospital Medical center

g. Length of time treating T2DM patients
i.

5 years

ii.

6-10 years

iii.

11-15 years

iv.

16-20 years

v.

20 or more years

h. Number of T2DM patients seen in a day
i.

1-10

ii.

11-20

iii.

21-30

iv.

31-40

v.

41 or more
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Appendix E: Recruitment Letter to Participants
Dear Sir or Madam:
My name is Vickie Bland, and I am a doctoral student at Walden University. I am
currently seeking participants for my doctoral dissertation study and am writing to see if you
would like to participate in my study. . I am studying physicians’ or nurse practitioners’
perspectives on depression screening within diabetic patients and am currently seeking
physicians or nurse practitioners to participate in this study.
Participation in this research is voluntary and involves participating in one 60-minute
interview. I plan to interview a select number of medical professionals’ face to face or a
telephone call in this study.
All of your responses to the interview questions will be kept anonymous. . The interview
will take 60 minutes, and the interview will be scheduled convenient to you and your workplace.
If you would like to participate, please respond to this email indicating you are interested in
participating. A follow-up email will then be sent to confirm participation and to schedule an
interview time.

Sincerely yours,
Vickie Bland

